IL-1β is considered to be a central factor for gastric malignancy, as is supported by evidence that IL-1B gene polymorphism increases the risk of gastric cancer (30, 31) and overexpression of IL-1β leads to gastric inflammation and cancers in mice (7, 9). The gene discussed is IL1B; the disease is cancer.